Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies

M. E. Sotomayor, K. Rao, Diana M Lopez, A. Liepins

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Ukrain is a semisynthetic drug with immunomodulatory properties, derived from Chelidonium majus L. alkaloids and thiophosphoric acid. The effect of this compound on the growth of Balb/c syngenic mammary adenocarcinoma was assessed. Intravenous, but not subcutaneous or intraperitoneal, administration of this drug was found to be effective in delaying tumour growth in an actual therapeutic protocol initiated five days after tumour implantation. No untoward side-effects were observed using these in vivo treatment modalities. The role of macrophages in the observed retardation of tumour development was investigated using peritoneal exudate macrophages (PEM) in cytotoxicity assays. In previous studies, the authors have found that PEM of mammary tumour bearing mice lose their capacity to kill a variety of tumour target cells Including the in vitro cultured homologous tumour cells (DA-3). Pretreatment of PEM from normal mice with 2.5μM Ukrain for 2.5h followed by stimulation with either IFN-γ or with LPS+IFN-γ enhanced their cytotoxic activity. Treatment of PEM from tumour bearing mice with 2.5μM Ukrain and LPS results in a reversal of their defective cytotoxic response against the DA-3 target cells. Furthermore, Ukrain alone, in the absence of a secondary signal, induced the activation of tumouricidal function of PEM from tumour bearing but not from normal mice. These data indicate that Ukrain's in vivo effects against the development of mammary tumours may be due, at least in part, to its ability to restore macrophage cytolytic function.

Original languageEnglish
Pages (from-to)5-11
Number of pages7
JournalDrugs under Experimental and Clinical Research
Volume18
Issue numberSUPPL.
StatePublished - Dec 1 1992
Externally publishedYes

Fingerprint

ukrain
Alkaloids
Peritoneal Macrophages
Exudates and Transudates
Macrophages
Neoplasms
Chelidonium
Breast Neoplasms
Cultured Tumor Cells
Growth
Pharmaceutical Preparations
In Vitro Techniques
Adenocarcinoma
Breast

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology (medical)
  • Drug Discovery
  • Pharmacology

Cite this

Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies. / Sotomayor, M. E.; Rao, K.; Lopez, Diana M; Liepins, A.

In: Drugs under Experimental and Clinical Research, Vol. 18, No. SUPPL., 01.12.1992, p. 5-11.

Research output: Contribution to journalArticle

@article{1d6c55949b7f4ec28468dc38c211ad47,
title = "Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies",
abstract = "Ukrain is a semisynthetic drug with immunomodulatory properties, derived from Chelidonium majus L. alkaloids and thiophosphoric acid. The effect of this compound on the growth of Balb/c syngenic mammary adenocarcinoma was assessed. Intravenous, but not subcutaneous or intraperitoneal, administration of this drug was found to be effective in delaying tumour growth in an actual therapeutic protocol initiated five days after tumour implantation. No untoward side-effects were observed using these in vivo treatment modalities. The role of macrophages in the observed retardation of tumour development was investigated using peritoneal exudate macrophages (PEM) in cytotoxicity assays. In previous studies, the authors have found that PEM of mammary tumour bearing mice lose their capacity to kill a variety of tumour target cells Including the in vitro cultured homologous tumour cells (DA-3). Pretreatment of PEM from normal mice with 2.5μM Ukrain for 2.5h followed by stimulation with either IFN-γ or with LPS+IFN-γ enhanced their cytotoxic activity. Treatment of PEM from tumour bearing mice with 2.5μM Ukrain and LPS results in a reversal of their defective cytotoxic response against the DA-3 target cells. Furthermore, Ukrain alone, in the absence of a secondary signal, induced the activation of tumouricidal function of PEM from tumour bearing but not from normal mice. These data indicate that Ukrain's in vivo effects against the development of mammary tumours may be due, at least in part, to its ability to restore macrophage cytolytic function.",
author = "Sotomayor, {M. E.} and K. Rao and Lopez, {Diana M} and A. Liepins",
year = "1992",
month = "12",
day = "1",
language = "English",
volume = "18",
pages = "5--11",
journal = "Drugs under Experimental and Clinical Research",
issn = "0378-6501",
publisher = "Bioscience Ediprint Inc.",
number = "SUPPL.",

}

TY - JOUR

T1 - Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies

AU - Sotomayor, M. E.

AU - Rao, K.

AU - Lopez, Diana M

AU - Liepins, A.

PY - 1992/12/1

Y1 - 1992/12/1

N2 - Ukrain is a semisynthetic drug with immunomodulatory properties, derived from Chelidonium majus L. alkaloids and thiophosphoric acid. The effect of this compound on the growth of Balb/c syngenic mammary adenocarcinoma was assessed. Intravenous, but not subcutaneous or intraperitoneal, administration of this drug was found to be effective in delaying tumour growth in an actual therapeutic protocol initiated five days after tumour implantation. No untoward side-effects were observed using these in vivo treatment modalities. The role of macrophages in the observed retardation of tumour development was investigated using peritoneal exudate macrophages (PEM) in cytotoxicity assays. In previous studies, the authors have found that PEM of mammary tumour bearing mice lose their capacity to kill a variety of tumour target cells Including the in vitro cultured homologous tumour cells (DA-3). Pretreatment of PEM from normal mice with 2.5μM Ukrain for 2.5h followed by stimulation with either IFN-γ or with LPS+IFN-γ enhanced their cytotoxic activity. Treatment of PEM from tumour bearing mice with 2.5μM Ukrain and LPS results in a reversal of their defective cytotoxic response against the DA-3 target cells. Furthermore, Ukrain alone, in the absence of a secondary signal, induced the activation of tumouricidal function of PEM from tumour bearing but not from normal mice. These data indicate that Ukrain's in vivo effects against the development of mammary tumours may be due, at least in part, to its ability to restore macrophage cytolytic function.

AB - Ukrain is a semisynthetic drug with immunomodulatory properties, derived from Chelidonium majus L. alkaloids and thiophosphoric acid. The effect of this compound on the growth of Balb/c syngenic mammary adenocarcinoma was assessed. Intravenous, but not subcutaneous or intraperitoneal, administration of this drug was found to be effective in delaying tumour growth in an actual therapeutic protocol initiated five days after tumour implantation. No untoward side-effects were observed using these in vivo treatment modalities. The role of macrophages in the observed retardation of tumour development was investigated using peritoneal exudate macrophages (PEM) in cytotoxicity assays. In previous studies, the authors have found that PEM of mammary tumour bearing mice lose their capacity to kill a variety of tumour target cells Including the in vitro cultured homologous tumour cells (DA-3). Pretreatment of PEM from normal mice with 2.5μM Ukrain for 2.5h followed by stimulation with either IFN-γ or with LPS+IFN-γ enhanced their cytotoxic activity. Treatment of PEM from tumour bearing mice with 2.5μM Ukrain and LPS results in a reversal of their defective cytotoxic response against the DA-3 target cells. Furthermore, Ukrain alone, in the absence of a secondary signal, induced the activation of tumouricidal function of PEM from tumour bearing but not from normal mice. These data indicate that Ukrain's in vivo effects against the development of mammary tumours may be due, at least in part, to its ability to restore macrophage cytolytic function.

UR - http://www.scopus.com/inward/record.url?scp=0027083148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027083148&partnerID=8YFLogxK

M3 - Article

C2 - 1305044

AN - SCOPUS:0027083148

VL - 18

SP - 5

EP - 11

JO - Drugs under Experimental and Clinical Research

JF - Drugs under Experimental and Clinical Research

SN - 0378-6501

IS - SUPPL.

ER -